Stock Events

Stock Events

Sangamo Therapeutics (SGMO) Q3 2026 Earnings

11AugConfirmed

Q3 2025

Q4 2025

Q2 2026

Q3 2026

-0.11

-0.07

-0.03

0.01

Details

Expected EPS

-0.07

Actual EPS

N/A

Surprise EPS

0.07

Surprise Percent

+100%

Description

Sangamo Therapeutics (SGMO) will report earnings of for Q3 2026 on August 11, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.